A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy.
Wissing KM, Morelon E, Legendre C, De Pauw L, LeBeaut A, Grint P, Maniscalki M, Ickx B, Vereerstraeten P, Chatenoud L, Kreis H, Goldman M, Abramowicz D.
Wissing KM, et al. Among authors: morelon e.
Transplantation. 1997 Oct 15;64(7):999-1006. doi: 10.1097/00007890-199710150-00012.
Transplantation. 1997.
PMID: 9381549
Clinical Trial.